<乌鸦传媒>The Cardiologist's PCSK9 Script: 6 Months of Frustration The 'honestly ridiculous' process William O'Neill, MD, faced for his own Rx Jun 11, 2018
<乌鸦传媒>Plan Announced to Simplify PCSK9 Access "Attestation" to replace one pharmacy benefit manager's extensive prior authorization for Praluent Jun 11, 2018
<乌鸦传媒>Diet During Pregnancy May Cut Offspring Allergy Risk Probiotics linked to reduced eczema risk; fish oil to lower risk of egg allergy May 18, 2018
<乌鸦传媒>Strong Eczema Response to JAK Inhibitor Half of patients achieved EASI 90 at 16 weeks May 18, 2018
<乌鸦传媒>Using Biology of Atopic Dermatitis to Improve Therapy Following psoriasis model of molecular targeting May 18, 2018
<乌鸦传媒>Evolocumab Wins FDA Approval for Stand-Alone CVD Prevention Will more patients now gain access to PCSK9 inhibitors? Apr 12, 2018
<乌鸦传媒>Praluent Delivers CV Event Prevention in ODYSSEY Second PCSK9 outcomes trial comes out like FOURIER -- but with mortality reduction Apr 12, 2018
<乌鸦传媒>NAMS: 'Take the Fear Out' of Hormone Therapy JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement Mar 19, 2018
<乌鸦传媒>Study: No Benefit for PT in Parkinson's Disease Physical therapy didn't improve function or quality of life in trial Jan 01, 2018
<乌鸦传媒>Parkinson's Disease: Prevalence Seen as Rising Biggest spike seen in men 70 years of age and up Jan 01, 2018
<乌鸦传媒>Inhaled Levodopa Cuts Motor Symptoms in Parkinson's 'Off' Episodes Drugmaker Acorda to seek FDA approval shortly Jan 01, 2018
<乌鸦传媒>Cognitive Dysfunction May Tell of Early Parkinson's Risk Baseline cognition associated with parkinsonism risk over 8 years Jan 01, 2018
<乌鸦传媒>Enthesitis Predicts Damage in PsA Severe enthesitis linked with worse peripheral and axial joint outcomes Dec 01, 2017
<乌鸦传媒>JAK Inhibitors Showing Promise for Many Skin Problems Conditions ranging from alopecia to vitiligo Nov 06, 2017
<乌鸦传媒>C-Section: Independent Risk Factor for Postpartum VTE On average, three in 1,000 women will develop VTE after procedure Nov 01, 2017
<乌鸦传媒>Testosterone Supplements Linked to VTE Risk Timing and duration of hormone therapy could be the issue Nov 01, 2017
<乌鸦传媒>Catheter-Based Tx Disappoints for Deep Vein Thrombosis Thrombolytic tx didn't cut post-thrombotic syndrome in trial Nov 01, 2017
<乌鸦传媒>ACC: Even Very Low Dose Rivaroxaban Prevents Recurrent VTE Results from EINSTEIN CHOICE point to new clinical pathway Nov 01, 2017
<乌鸦传媒>Osteoporosis Drug Use Falls Short Only about one in five postmenopausal women received appropriate meds Oct 06, 2017
<乌鸦传媒>Prolia Benefits Persist to a Decade in Postmenopausal Women Further decreases in nonvertebral fractures with longer treatment Oct 06, 2017
<乌鸦传媒>Add-On Nucala Does, and Doesn't, Reduce COPD Exacerbations Significant benefit in METREX trial but not in METREO Aug 09, 2017
<乌鸦传媒>Genomic Testing Helps Cancer Patients -- When Results are Used Also, liquid biopsy can ID drug-responsive tumors Jul 20, 2017
<乌鸦传媒>What's the Role of NSAIDs in Back Pain? Meta-analysis says "minimal" but diagnosis can confound Jul 19, 2017
<乌鸦传媒>Dupixent: Injection for Eczema Wins FDA Nod Approved for patients not responding to or unable to use topical agents Jul 06, 2017
<乌鸦传媒>HCV Treatment Can Avert Transplant Even in Severe Disease A quarter of patients with decompensated cirrhosis could safely get off waiting list Jul 05, 2017
<乌鸦传媒>Anti-VEGF Tx for Wet AMD Shows Benefit 5 Years Later Half of patients still had 20/40 vision or better Jun 01, 2017
<乌鸦传媒>AAO: Fruit and Caffeine May Reduce AMD Risk Micronutrient analysis also found protective effect of fiber, beta carotene, vitamins C and E Jun 01, 2017
<乌鸦传媒>More Bevacizumab Shots for AMD May Up Risk of Glaucoma Repeated injections tied to increased ocular pressure, higher rates of surgery Jun 01, 2017
<乌鸦传媒>Repeated Intravitreal Injections Linked to Glaucoma 7 or more bevacizumab injections per year may double risk of glaucoma surgery Jun 01, 2017
<乌鸦传媒>OncoBreak: 'Just Not Ready' for Hospice; Old Drugs, New Diseases News, features, and commentary about cancer-related issues May 24, 2017
<乌鸦传媒>FDA Panel Pans Bladder Cancer Therapy Too few patients, modest benefit cited in negative vote Mar 08, 2017
<乌鸦传媒>Image-Guided Radiation for Bladder Ca: New Standard of Care? Three-year rate of bladder preservation was 83% Mar 08, 2017
<乌鸦传媒>Stroke Risk Dooms Once-Promising Bone Drug 32% more strokes seen with odanacatib; development halted Dec 07, 2016
<乌鸦传媒>Novel Osteoporosis Drug Fares Well in Phase III Trial 18-month NNT of 28 for spine fracture in low-risk women Dec 07, 2016
<乌鸦传媒>Analysis Shows Unreliable Results in Osteoporosis Studies Study author admits fraud to Neurology Dec 07, 2016